Michigan Biosciences Industry Association Logo

Federal Advocacy

Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
Attempts to Regulate Drug Pricing Fail During Legislative Chaos
Posted In: Federal Advocacy,
Date posted Dec 31

Discover the latest on drug pricing reforms in Michigan, including legislative challenges and opposition from key industry groups like MichBio and...

Read Post
Biosecure Act Fails to be Enacted
Posted In: Federal Advocacy,
Date posted Dec 31

Stay updated on the BIOSECURE Act's challenges in Congress and its implications for U.S. biotech. Learn more about MichBio's advocacy efforts.

Read Post
CMS Finalizes Accelerated Approval Pathway for Devices
Posted In: Federal Advocacy,
Date posted Dec 31

Explore MichBio's resources for the bio-industry, including membership benefits, events, advocacy, and the latest news on medical technology...

Read Post
Ensuring Patient Access to Critical Breakthrough Products
Posted In: Federal Advocacy,
Date posted Dec 31

Stay informed on the "Ensuring Patient Access to Critical Breakthrough Products Act," aimed at expediting Medicare coverage for innovative medical...

Read Post
House Approves BIOSECURE Act
Posted In: Federal Advocacy,
Date posted Oct 22

Stay updated on the BIOSECURE Act's passage and its implications for biotechnology contracts. Learn about its provisions and potential impacts on...

Read Post
CMS Finalizes Expedited TCET Coverage Pathway
Posted In: Federal Advocacy,
Date posted Aug 28

Discover MichBio's latest news on the new TCET coverage pathway, expediting Medicare for FDA-approved devices. Stay informed on bioscience...

Read Post
First Drugs Subject to Inflation Reduction Act Price Provisions
Posted In: Federal Advocacy,
Date posted Aug 28

Stay informed on MichBio's advocacy for drug price negotiations under the Inflation Reduction Act, impacting Medicare and innovation in the biotech...

Read Post
FTC Meeting Highlights Urgent Need for PBM Reforms To Protect Patients
Posted In: Federal Advocacy,
Date posted Aug 28

Join MichBio in advocating for Pharmacy Benefit Manager reforms to enhance patient access to affordable medications. Stay informed on bioscience...

Read Post
Proposed USPTO Rules Likely to Cause Harm
Posted In: Federal Advocacy,
Date posted Jul 11

Discover MichBio's advocacy against proposed USPTO rules that threaten patent integrity and innovation in the bio-industry. Stay informed and engaged!

Read Post
Understanding the Department of Labor's New Worker Classification Rule
Posted In: Federal Advocacy,
Date posted May 28

Stay informed on the DOL's new worker classification rule affecting independent contractors. Learn how it impacts employer obligations and worker...

Read Post
Efforts Continue to Repeal Onerous R&D Amortization Rules
Posted In: Federal Advocacy,
Date posted Mar 27

Stay updated on MichBio's advocacy for R&D tax policy reform, supporting innovation in Michigan's bio-industry. Learn more about our initiatives...

Read Post